Plain-English translation of NCT06368310 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is one of the first times this treatment has been tested in people.
This is the first human study of a brand new type of electrode called a graphene micro-electrocorticography array. These electrodes are much thinner and more flexible than standard brain electrodes and use a special carbon material that can detect electrical brain signals more sensitively. If you join this study, surgeons would use these new electrodes during your planned brain tumor removal surgery to map which areas of your brain control important functions like movement and speech.
Current brain electrodes have limits — they don't bend well to fit the brain's shape, need to be quite large to pick up signals, and can't always be placed where they're needed most. This trial exists to test whether the new graphene electrodes solve these problems, potentially giving surgeons better information to protect critical brain areas during your operation.
You likely qualify if…
You likely don't qualify if…
You would be having brain surgery anyway as part of your standard care. During this surgery, surgeons would use the new graphene electrodes instead of (or alongside) standard electrodes to map your brain function. The surgery itself is similar to what you would normally have, but with the added benefit of these improved monitoring tools. Your care team would monitor you during and after surgery as they normally would.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United Kingdom